News

Synthetic peroxide drug candidate OZ439 in phase II clinical trials

An international consortium with the Swiss TPH represented by Reto Brun and Sergio Wittlin reports in its latest issue of the scientific journal PNAS (doi:10.1073/pnas.1015762108) on a synthetic molecule, OZ439, that gives...more

Rudolf Geigy Award Winner 2010

At this year's Autumn Symposium the Geigy Foundation has awarded the R. Geigy Award to Dr. Esther Schelling. The R. Geigy Foundation's purpose is to support the Swiss Tropical and Public Health Institut in its mandate to...more

New Biennial Report

The Swiss Tropical and Public Health Institute is pleased to present the Biennial Report 2009-2010. more

Prenatal contact with farm animals protects children from atopic dermatitis at age 2

Researchers found that children with mothers having contact with farm animals and cats during their pregnancies had a reduced risk of developing atopic dermatitis in the first 2 years of life. The authors from the University of...more

The drug tribendimidine seems to be as safe as the drug of choice, praziquantel against infection with the Southeast Asian liver fluke

The drug tribendimidine seems to be as safe and effective as the drug of choice, praziquantel, against infection with the Southeast Asian liver fluke (Opisthorchis viverrini), providing almost complete egg elimination and a...more

University of Basel awards Honorary Doctorate to Professor Joel Schwartz

The Swiss TPH congratulates Professor Joel Schwartz of the Harvard School of Public Health, Boston (USA) on the award of an Honorary Doctorate by the University of Basel. Professor Schwartz is known as the most productive...more

Researchers from Basel find improved treatment outcomes against whipworm infections by administration of a combination treatment

Researchers from the Swiss Tropical and Public Health Institute in Basel, together with partners from Tanzania and the UK have tested – for the first time – a combination treatment of mebendazole plus ivermectin against...more